Cocrystal Pharma (COCP) Amortizatization of Intangibles (2019 - 2021)
Cocrystal Pharma (COCP) posted Amortizatization of Intangibles of $47000.0 for Q1 2021, up 2.17% sequentially from $46000.0 in Q4 2020, and up 6.82% YoY from $44000.0 in Q1 2020.
Cocrystal Pharma (COCP) Amortizatization of Intangibles (2019 - 2021) Analysis & Trends
Cocrystal Pharma has reported Amortizatization of Intangibles for 3 years, with the latest figure at $47000.0 in Q1 2021.
- Quarterly Amortizatization of Intangibles rose 6.82% year-over-year to $47000.0 in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $191000.0 (up 20.89% YoY) and the FY2020 annual result came in at $179000.0, up 14.74% from the prior year.
- Amortizatization of Intangibles rose to $47000.0 in Q1 2021 per COCP's latest filing, from $46000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $54000.0 in Q4 2019 and troughed at $17000.0 in Q3 2019.
- A 3-year average of $41833.3 and a median of $45000.0 in 2020 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2020 and 2021: Amortizatization of Intangibles fell 14.81% in 2020, then gained 6.82% in 2021.
- Over 3 years, Amortizatization of Intangibles stood at $54000.0 in 2019, then dropped by 14.81% to $46000.0 in 2020, then gained by 2.17% to $47000.0 in 2021.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $47000.0, $46000.0, and $44000.0 for Q1 2021, Q4 2020, and Q1 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 47,000.00 |
| Mar 31, 2021 | 47,000.00 |
| Dec 31, 2020 | 46,000.00 |
| Dec 31, 2020 | 46,000.00 |
| Mar 31, 2020 | 44,000.00 |
| Mar 31, 2020 | 44,000.00 |
| Dec 31, 2019 | 54,000.00 |
| Dec 31, 2019 | 54,000.00 |
| Sep 30, 2019 | 17,000.00 |
| Sep 30, 2019 | 17,000.00 |
| Mar 31, 2019 | 43,000.00 |
| Mar 31, 2019 | 43,000.00 |